Table 4.
Influence of obesity on novel or emerging risk factors.
| Parameter | BMI < 30 | BMI ≥ 30 | P value |
|---|---|---|---|
| Inflammatory marker (n = 56; n = 55) | |||
| CRP (mg·L−1) | 1.81 ± 2.04 | 2.80 ± 2.01 | 0.011 |
| Vascular measures (n = 56; n = 60) | |||
| Aortic systolic pressure (mm Hg) | 118 ± 11 | 121 ± 13 | 0.169 |
| Aortic diastolic pressure (mm Hg) | 85 ± 8 | 87 ± 8 | 0.304 |
| Augmentation index @ 75 (%)† | 13 ± 10 | 11 ± 10 | 0.217 |
| Time of reflected wave (ms) | 150 ± 12 | 152 ± 13 | 0.354 |
| Buckberg SEVR (%) | 181 ± 31 | 168 ± 25 | 0.012 |
| ED/period (%) | 33 ± 4 | 34 ± 4 | 0.041 |
Values are mean ± SD. †Augmentation index normalized to a heart rate of 75 beats per minute. BMI: body mass index; CRP: high-sensitivity C-reactive protein; SEVR: subendocardial viability ratio; ED/period: ejection duration index.